Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
HUMBER TEACHING NHS FOUNDATION TRUST
RV9
Trust HQ, Willerby Hill, Beverley Road, Willerby
Hull
HU106ED
UK
Person cyswllt: Chris Rounce
E-bost: chris.rounce@nhs.net
NUTS: UKE12
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.humber.nhs.uk/
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Drug and Alcohol Treatment, Primary Care Interventions and Shared Care
Cyfeirnod: C347665
II.1.2) Prif god CPV
85323000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
Drug and Alcohol Treatment, Primary Care Interventions and Shared Care.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 1 435 194.00 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKE
II.2.4) Disgrifiad o’r caffaeliad
Drug and Alcohol treatment, Primary Care Interventions and Shared Care.
We are intending to award a contract to an existing provider following Direct Award Process C.
Value of the contract £1,435,194
The service will be provided between 01/04/2025 - 31/03/2029
II.2.5) Meini prawf dyfarnu
Maen prawf cost: The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard
/ Pwysoliad: 100
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Mae’r caffaeliad y tu allan i gwmpas cymhwysiad y gyfarwyddeb
Esboniad
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by
02/04/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
Section V: Dyfarnu contract
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
20/03/2025
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
The Alcohol and Drug Service
1108595
Hull
UK
NUTS: UKE11
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Amcangyfrif cychwynnol o gyfanswm gwerth y contract/lot: 1 435 194.00 GBP
Cyfanswm gwerth y contract/lot: 1 435 194.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 02/04/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Written representations should be sent to Phillip.Simmons@nhs.net
Award decision-makers; Dawn Fawcett and Matthew Handley
The relative importance of the key criteria that the relevant authority used to make a decision, the rationale for the relative importance of the key criteria, and the rationale for choosing the provider with reference to the key criteria.
Pass/Fail
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
Independent patient choice and procurement panel
London
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
21/03/2025